China is experiencing an outbreak of a new virus referred to as human metapneumovirus (HMPV). The virus is most likely to ...

It is fair to say that the year 2024 was a 'dramatic' one, in which two major life-threatening epidemics were recorded but safely controlled and key achievements were registered in Rwanda's efforts to ...

SIGA Technologies has gained Japanese regulatory approval for TEPOXX (tecovirimat) 200mg capsules, known as TPOXX in the US, ...

Nepal has confirmed two additional cases of mpox among migrant workers, according to health authorities on Friday. With the ...

A new laboratory has been created in Wiltshire to boost the UK's ability to fight future pandemics. The Diagnostic ...

These two mpox cases point to the hazardous conditions and risky behaviours of Nepali migrant workers. Several international ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

TPOXX is approved in the U.S. and Canada for the treatment of smallpox. In the European Union and United Kingdom, marketed as Tecovirimat-SIGA, it is approved for the treatment of smallpox, mpox, ...

Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as ...

SIGA Technologies (SIGA) stock gains as Japan approves antiviral Tepoxx as a treatment for orthopoxviruses including mpox.

The Ministry of Health has urged Kenyans to exercise caution amid a new wave of MPOX infections spreading rapidly across the ...